<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200120046197N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-02-26</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Metformin Combination  with Double Antibiotic Paste (DAP)  in Tooth Pulp Regeneration</public_title>
      <acronym></acronym>
      <scientific_title>Comparison  of the Effect of  Double Antibiotic Paste Alone or in Combination with Metformin  on Regeneration of Non-Vital Immature Teeth: A Pilot Clinical Study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45140</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Randomization Method was used for the Patient's Allocation into two groups with a 1:1 Ratio by RANDOM.ORG Software.
Participants were divided into two Groups of Double Antibiotic Paste Revascularization techniques with and without Metformin, Blinding description: The  Double Antibiotic pastes with the same Color, Consistency, and Volume are delivered in the same Container to the Practitioner.
Participants ( patients) have no idea about the materials that were used for them. 
Observers  have no Idea about the materials which are used for the Patients.
The Researcher is the only one who knows about suggested  Materials which is used for each Patient and leads the Research.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Tooth Pulp Necrosis.</hc_freetext>
      <i_freetext>Intervention 1: Control group: the tooth is anesthetized, isolated, and accessed. After determining the working length, the canals should be copiously irrigated with NAOCL 1.5%followed by 17% EDTA. Canals were dried with sterile paper points and double antibiotic paste (DAP) as a mixture of Ciprofloxacin 500 mg  (Tolidaru Co.) and Metronidazole 250mg (Kosar Co.) at the concentration of 1mg/ml is placed into the canals for 3-4weeks. In the second appointment, canals should be irrigated with 17%EDTA, and after the creation of bleeding with a No.25 file, on top of the coagulum, about 3 mm of MTA is then placed. Intervention 2: Intervention group: the tooth is anesthetized, isolated, and accessed. After determining the working length, the canals should be copiously irrigated with NAOCL 1.5%followed by 17% EDTA. Canals were dried with sterile paper points and double antibiotic paste (DAP) as a mixture of Ciprofloxacin 500 mg  (Tolidaru Co.) and Metronidazole 250mg (Kosar Co.) Adding Metformin 500mg  (Abidi Co.) with the same volume of antibiotics at the concentration of 1mg/ml is placed into the canals for 3-4weeks. In the second appointment, canals should be irrigated with 17%EDTA, and after the creation of bleeding with No.25 file, on top of the coagulum, about 3 mm of MTA is then placed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The result of study consist of clinical and radiographic findings of participants due to the kind of materials which was used

When:
6 months after publishing

To whom:
No limit

Conditions:
With referencing of the article

Where to obtain:
Corresponding author

How to obtain:
Written request by email for corresponding author. One month after the permission of all authors

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Fariborz Moazami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz dental School, Ghasrdasht St.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۷۱۹۵۶-۱۵۸۷۸</zip>
        <telephone>+98 71 3626 3193</telephone>
        <email>fmoazzami@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr, Fariborz Moazmi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz dental school , Ghasrdasht St.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71956-15878</zip>
        <telephone>+98 71 3626 3194</telephone>
        <email>fmoazzami@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Non- Vital Permanent Teeth with Open Apex(File size equal or more than 60)
With or without Radiographic Radiolucency
Negative Response to Pulp Vitality Test
Restorable Tooth
No Systemic Conditions</inclusion_criteria>
      <agemin>7 years</agemin>
      <agemax>11 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Severe periodontal disease,
Internal and external root resorption</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>-</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>-</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: the tooth is anesthetized, isolated, and accessed. After determining the working length, the canals should be copiously irrigated with NAOCL 1.5%followed by 17% EDTA. Canals were dried with sterile paper points and double antibiotic paste (DAP) as a mixture of Ciprofloxacin 500 mg  (Tolidaru Co.) and Metronidazole 250mg (Kosar Co.) at the concentration of 1mg/ml is placed into the canals for 3-4weeks. In the second appointment, canals should be irrigated with 17%EDTA, and after the creation of bleeding with a No.25 file, on top of the coagulum, about 3 mm of MTA is then placed.</i_keyword>
      <i_keyword>Intervention group: the tooth is anesthetized, isolated, and accessed. After determining the working length, the canals should be copiously irrigated with NAOCL 1.5%followed by 17% EDTA. Canals were dried with sterile paper points and double antibiotic paste (DAP) as a mixture of Ciprofloxacin 500 mg  (Tolidaru Co.) and Metronidazole 250mg (Kosar Co.) Adding Metformin 500mg  (Abidi Co.) with the same volume of antibiotics at the concentration of 1mg/ml is placed into the canals for 3-4weeks. In the second appointment, canals should be irrigated with 17%EDTA, and after the creation of bleeding with No.25 file, on top of the coagulum, about 3 mm of MTA is then placed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pulp revitalization. Timepoint: Before intervention and patient follow up for 3 and 12 months after intervention. Method of measurement: Clinical And Radiographic Assessment.</prim_outcome>
      <prim_outcome>Changes in diameter of root dentin with the regenerated tissues. Timepoint: Before intervention and patient follow up for 3 and 12 months after intervention. Method of measurement: Clinical And Radiographic Assessment.</prim_outcome>
      <prim_outcome>Changes the length of root with the regenerated tissues. Timepoint: Before intervention and patient follow up for 3 and 12 months after intervention. Method of measurement: Clinical And Radiographic Assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-05</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Shiraz Dental School , GHasrdasht St..reet Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
